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 ABSTRACT 
 
This report reviews the use of stepwise testing approaches for the prediction of skin 
and eye irritation and corrosion in a regulatory context. It is published as a companion 
report to the Review of Literature-Based Models for Skin and Eye Irritation and 
Corrosion, an ECB report which reviewed the state-of-the-art of in silico and in vitro 
dermal and ocular irritation and corrosion human health hazard endpoints. In the 
former review, the focus was placed on reviewing alternative in silico approaches to 
assess acute local toxic effects, such as QSARs, SARs, chemical categories, and read-
across and analogue approaches. Special emphasis was placed on literature-based 
(Q)SAR models for skin and eye irritation and corrosion and expert systems. In the 
present review, the emphasis is on different schemes (testing strategies) that have 
been conceived for the integrated use of different approaches, including in silico, in 
vitro and in vivo methods. 
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1. Introduction 
Toxicological testing of chemicals for risk assessment, aiming at the prediction of 
adverse effects to human health and the environment, involves high costs, in terms of 
time, money, and animal welfare. To perform testing effectively in the regulatory 
context, chemicals should be adequately selected and prioritised for testing, and 
improved predictive test systems for new endpoints of concern should be designed. 
There is an urgent need for test strategies that can fill the data gaps for a large number 
of untested substances as efficiently as possible. Such strategies must take into 
account the limitations in economic resources and testing capacity. They also have to 
be in line with the aim to reduce the use of animals for toxicity testing.  
A test system consists of a set of individual tests and a system of rules and 
criteria that are used to select tests for each individual substance and to determine in 
which order they are performed. In testing systems, relatively simple tests are 
performed for all the chemicals to be assessed. The outcomes of the initial tests are 
then used to prioritise substances for additional, more resource-intensive testing.  
Two types of strategies can be formulated: animal-free strategies comprise in 
silico and in vitro data, whereas reductive strategies (i.e. strategies which reduce the 
need for animal testing) also take into account in vivo data. For both types of 
strategies, tiered and integrative strategies can be envisaged. In a tiered strategy, the 
data are generated stepwise. The decision at each step is based only on the newly 
generated data, without taking into account the previous information. Integrative 
strategies can either be stepwise, or a battery. In a stepwise integrated strategy, the 
data are also generated stepwise. However, the decision at each step is based on all the 
available data at that step. Finally, in a battery strategy all data are generated 
simultaneously. There is only one decision point, which considers all data. In this 
document, both tiered and integrative strategies will be considered. 
The use of ITS have become widespread in the pharmaceutical field, where 
large numbers of candidate test substances need to be tested and screened to filter the 
ones likely to be toxic in subsequent testing [1]-[2]. They are also very useful in 
chemical assessment for the evaluation and prioritisation of large number of 
chemicals, based on early predictions of their potential toxicity. With the 
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implementation of REACH, integrated testing strategies are especially relevant within 
the regulatory context [3]-[4]. 
In the regulatory context, Integrated Testing Strategies (ITS), which are used 
to make classification decisions on the basis of non-animal data or to evaluate whether 
in vivo testing is needed, are widely used. These strategies consist of a series of tests 
performed in a defined sequential manner. The tests selected in each successive level 
are determined by the results in the previous level of testing in a stepwise process that 
leads to a decision. Testing strategies start by using existing data to enable in silico 
based toxicity predictions, including the application of (Q)SARs and decision models 
based on physicochemical data. In a successive step they also encompass the use of in 
vitro methods, and only if necessary they consider the application of in vivo tests. 
Special focus is made on the prospects for using (Q)SAR modelling and read-across 
as part of integrated testing strategies for chemical risk assessment [5]. However, 
future perspectives envisage the use of promising innovative techniques, such as 
genomics, proteomics, metabonomics for improved strategies for toxicity prediction 
[6]-[7]. 
Decision-tree schemes are also commonly used intelligent testing schemes 
within regulatory frameworks. In this type of strategy, at certain stages in each 
scheme, a decision on whether to classify and label and/or to undertake a risk 
assessment with respect to the test substance is made via a Weight of Evidence (WoE) 
process [8]. The decision on whether to stop or continue testing depends on the 
amount and quality of the information available, and the validation status of the tests 
used to generate data at each WoE evaluation step. 
A rigorous strategy to combine single tests into efficient testing systems 
should be ideally based on standard decision theory. Such theory should include 
chemical, toxicological, and decision-theoretical knowledge, and take into account the 
optimisation of test systems, and also validity, reliability, sensitivity, and cost 
efficiency concepts [9]. The assessment of test performance characteristics, 
mechanistic understanding, extended quality assurance, formal validation and the use 
of integrated testing strategies should be performed to optimize the balance between 
safety, costs and animal welfare [10]. 
Acute local irritancy and corrosivity are mainly assessed in two contexts: in 
the hazard classification of industrial chemicals and in the safety assessment of 
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ingredients and mixtures used in industrial, pharmaceutical and consumer products. 
The intended purpose in each context is different, and therefore the considerations 
made in the two situations are not equivalent.  
In the hazard identification of chemicals, the purpose of testing is to assess the 
irritation/corrosion potential according to classification schemes defined by regulatory 
authorities. Current regulatory proposals recommend a stepwise approach to hazard 
identification in which chemicals can be classified as irritating/corrosive on the basis 
of results from non-animal methods. Since testing in animals is only required as a last 
step to confirm negative results generated by non-animal tests, these testing strategies 
contribute to the reduction and refinement of in vivo tests. The non-animal methods 
act as partial replacements of the animal test screens, being used to place chemicals 
into two or more categories of irritation/corrosion potential, without generating too 
many false positive results. In such strategies, there is less concern about the 
generation of false negatives because these can be identified by the animal tests 
carried out in the last step of the process.  
In contrast, in the safety assessment of ophthalmologic and cosmetic 
ingredients, mixtures and products, the purpose is to demonstrate that the products 
will not cause adverse effects. In this case, the placement of test substances into broad 
irritation/corrosion categories is often not sufficient, since it is necessary to establish 
the absence of adverse effects at lower concentrations. Although there is an increasing 
reliance on non-animal methods, it is more challenging to assess the reliability of 
predictions for product safety. 
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2. Seminal testing strategies for eye irritation 
In 1991, the Interagency Regulatory Alternatives Group (IRAG), an ad hoc 
organization composed of staff from U.S. regulatory agencies, sponsored an 
international workshop to propose updates for in vivo eye irritation test methods. As a 
result, a testing and evaluation scheme for the determination of eye irritation potential 
of chemicals was proposed. The IRAG testing process starts with initial 
considerations before commencing animal testing on a chemical, specifically on 
physicochemical properties including pH extremes, and the use of potential buffering 
capacity information; evidence of dermal irritation or corrosivity; validated and 
accepted non-whole animal (in vitro) alternatives; structure-activity relationships 
(SAR); and human experience. A sixth parameter, acute dermal toxicity, was 
considered because any acute toxic agent via dermal route is assumed to be also toxic 
to the eye. The resulting scheme, which takes into account a Weight of Evidence 
(WoE) approach for judgement, is shown in Figure 1. 
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Figure 1. IRAG tiered scheme for eye irritation testing. [11]. 
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 In April 1993, the German competent authority for the regulatory assessment 
of chemicals presented a decision-tree scheme for eye irritancy testing at a 
symposium in Ottawa [12]. The scheme, based on the experience evaluating test 
reports submitted under the EU New Chemicals notification procedure, is shown in 
Figure 2. Briefly the steps of this strategy can be summarised as follows:  
Measurement of pH (Step 1). Eye irritancy properties of strongly acidic (pH 
< 2) or alkaline substances (pH > 11.5) need not be tested because of their probable 
corrosive properties. Buffering capacity is also taken into account.  
Evaluation of skin corrosivity/irritancy (Step 2). Eye irritant properties of 
substances known to be corrosive to skin are not tested for ethical reasons, even 
though a number of skin corrosive substances demonstrate only mild eye irritation.  
Structure-activity-relationships considerations (Step 3). Theoretical 
considerations on qualitative structure-activity-relationships or computational 
chemical modelling to predict eye irritant properties are considered.  
In vitro methods or other alternative tests (Step 4). Results of validated 
alternative methods predicting serious eye irritant/corrosive effects to eyes may be 
sufficient for labelling the substances as R41. 
Draize eye test with one animal (Step 5). In the case of results showing 
severe irritant/corrosive effects, the substance is labelled as R41 and no further testing 
is required.  
Draize eye test with two additional animals (Step 6). If the outcome is 
negative after the last step, there is no indication of danger and, subsequently, no risk 
phrase is assigned. 
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Figure 2. Eye Irritancy Testing Strategy for New Chemicals within the Notification Procedure of 
the European Community [11]. 
 
As a result of discussions at the 1991 IRAG workshop, it became apparent that 
there were areas of consensus and areas where there were different opinions as to how 
the test should be performed and evaluated. Consequently, a second set of proposals 
for modifications to the 1987 OECD eye irritation test guideline was sent out for 
review and comment. After an international discussion, the proposals were submitted 
to OECD for additions and modifications, which resulted in a proposal for the revised 
TG 405 [13], and a tiered scheme for eye irritation testing to be annexed to the 
updated OECD guideline was worked out [14]. 
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3. Tiered testing strategy adopted by the GHS 
The recommended testing strategy in the Globally Harmonised System (GHS) for the 
Classification of Chemical Substances  [15] is based on a collection of test guidelines 
and classification schemes [16]. The IRAG scheme of the U.S. regulators (Figure 1), 
the experiences of the German regulators based on the EU chemicals notification 
procedure (Figure 2), and the outcome of the OECD Workshop on Harmonisation of 
Validation Criteria for Alternative Tests / Harmonisation and Acceptance Criteria for 
Alternative Toxicological Test Methods held in Solna, Sweden, in January 1996, were 
integrated into a single proposal for a testing strategy to be included in TG 405 [17]. 
Test methods in Annex V to Directive 67/548 for skin irritation/corrosion [18] 
and for eye irritation/corrosion [19] focus on possible improvements through the 
evaluation of all existing information on test substances. The sequential testing 
strategy provides a WoE approach for the evaluation of existing data on the 
irritation/corrosion properties of substances and a tiered approach for the generation 
of relevant data on substances for which additional studies are needed or for which no 
studies have been performed. For new substances this stepwise testing approach for 
developing scientifically sound data on the corrosivity/irritation of the substance is 
recommended. For existing substances with insufficient data on skin and eye 
corrosion/irritation, the strategy should be used to fill missing data gaps.  
 Prior to undertaking tests as part of the sequential testing strategy, all available 
information should be evaluated to determine the need for in vivo testing. Although 
significant information might be gained from the evaluation of single parameters, the 
totality of existing information should be assessed. All relevant data on the effects of 
the substance in question, and its structural analogues, should be evaluated in making 
a WoE decision, and a rationale for the decision should be presented. Primary 
emphasis should be placed upon existing human and animal data on the substance, 
followed by the outcome of in vitro or ex vivo testing. In vivo studies of corrosive 
substances should be avoided as far as possible. The testing strategies for eye 
irritation (Figure 3) and for skin irritation/corrosion (Figure 4) include the following 
steps: 
Evaluation of existing human and animal data (Step 1). Existing human 
data, e.g. clinical and occupational studies, and case reports, and/or animal test data 
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should be considered first. Substances with sufficient evidence of non-corrosivity and 
non-irritancy from previously performed studies should also not be tested in in vivo 
studies. 
 Analysis of structure activity relationships (SAR) (Step 2). The results of 
testing of structurally related chemicals should be considered, if available. When 
sufficient human and/or animal data are available on structurally related substances or 
mixtures of such substances to indicate their eye corrrosion/irritancy potential, it can 
be presumed that the test substance will produce the same responses. In those cases, 
the substance may not need to be tested. Conversely, negative data from studies of 
structurally related substances or mixtures of such substances do not constitute 
sufficient evidence of non-corrosivity/ non-irritancy of a substance. Valid and 
accepted SAR approaches should be used to identify the corrosion and irritation 
potential for both dermal and ocular effects.  
Physicochemical properties and chemical reactivity (Step 3). Substances 
exhibiting pH extremes such as pH ≤ 2.0 or pH ≥ 11.5 may have strong local effects. 
If extreme pH is the basis for identifying a substance as corrosive or irritant to the eye, 
then its acid/alkaline reserve (buffering capacity) may also be taken into 
consideration. If the buffering capacity suggests that a substance may not be 
corrosive, then further testing should be undertaken to confirm this, preferably by the 
use of a validated and accepted in vitro or ex vivo test. 
Consideration of other existing information (Step 4). All available 
information on systemic toxicity via the dermal route should be evaluated at this 
stage. If the test substance has been shown to be very toxic by the dermal route, it may 
not need to be tested in the eye. Although there is not necessarily a relationship 
between acute dermal toxicity and eye irritation/corrosion, it can be assumed that if an 
agent is very toxic via the dermal route, it will also exhibit high toxicity when instilled 
into the eye. 
Alternatively, for skin irritation/corrosion, if a chemical has proven to be very 
toxic by the dermal route, an in vivo dermal irritation/corrosion study may not be 
practicable because the amount of test substance normally applied could exceed the 
very toxic dose and, consequently result in the death or severe suffering of animals. 
 Results from in vitro or ex vivo tests (Steps 5 and 6). Substances that have 
demonstrated corrosive or severe irritant properties in an in vitro or ex vivo test that 
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has been validated and accepted for the assessment of eye or skin corrosivity/irritation 
do not need to be tested in animals. It can be presumed that such substances will 
produce similar severe effects in vivo.  
 Assessment of in vivo dermal irritancy or corrosivity of the substance 
(Step 7 for eye). This step is only carried out in the case of eye irritation/corrosion. 
When insufficient evidence exists with which to perform a conclusive WoE analysis 
of the potential eye irritation/corrosivity of a substance based upon data from the 
studies listed above, the in vivo skin irritation/corrosion potential should be evaluated 
first. If the substance is shown to produce corrosion or severe skin irritation, it should 
be considered to be a corrosive eye irritant unless other information supports an 
alternative conclusion. Thus, an in vivo eye test does not need to be performed. If the 
substance is not corrosive or severely irritating to the skin, an in vivo eye test should 
be performed. 
 In vivo test in rabbits (Step 8 and 9 for eye; Step 7 and 8 for skin). In vivo 
ocular testing should begin with an initial test using one animal. If the results of this 
test indicate the substance to be a severe irritant or corrosive to the eyes, further 
testing should not be performed. If that test does not reveal any corrosive or severe 
irritant effects, a confirmatory test is conducted with two additional animals. 
 In the case of skin irritation/corrosion, this corresponds to Steps 7 and 8. 
Should a WoE decision be made to conduct in vivo testing, it should also begin with 
an initial test using one animal. If the results of this test indicate the substance to be 
corrosive to the skin, further testing should not be performed. If a corrosive effect is 
not observed in the initial test, the irritant or negative response should be confirmed 
using up to two additional animals for an exposure period of four hours. If an irritant 
effect is observed in the initial test, the confirmatory test may be conducted in a 
sequential manner, or by exposing the two additional animals simultaneously. 
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Figure 3. Testing and Evaluation Strategy for Eye Irritation/Corrosion [19]. 
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Figure 4. Testing and Evaluation Strategy for Skin Irritation/Corrosion [18]. 
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4. Literature-based testing strategies 
In the literature, several stepwise hierarchical testing strategies have been proposed to 
hazard evaluation. They are also based on the sequential application of one or more 
alternative methods prior to the use of any animal test, with the purpose of reducing 
and refining the use of animals in toxicity testing without compromising human 
safety.  
Tiered assessment strategies have been applied jointly and separately to both 
endpoints. There is strong evidence that chemicals that are corrosive to the skin 
should also be classified as being corrosive to the eye, especially if the assessment is 
made from knowledge of acidity and alkalinity. In particular, in the EU and OECD 
classification schemes, chemicals that have been found to be corrosive to the skin are 
automatically considered to be corrosive to the eye as well (and are therefore labelled 
as such without animal testing). 
A report by Balls et al. [20] describes some initiatives aimed at the short-term 
reduction and refinement of animal use, and the long-term replacement of the Draize 
test in eye irritation testing. These initiatives included the evaluation of the use of 
reference standards (benchmark chemicals) in the validation process; an evaluation of 
tiered testing strategies; further analyses of the data generated during previous 
validation studies; and research into the mechanistic basis of eye irritation. Special 
emphasis was placed on the review of stepwise testing strategies. Hierarchical testing 
schemes proposed in the literature for skin irritation/corrosion [21]-[22], and 
proposals based on the combined use of a cytotoxicity test and an organotypic test 
[23]-[25] for eye irritation were cited. The tiered approach to eye irritancy/corrosivity 
testing provided in the 1987 update of OECD TG 405 [17] was also reviewed.  
A study published by Worth et al. [26] evaluated the use of a stepwise 
hierarchical testing strategy consisting of three steps to classify skin corrosives. The 
effect of applying the three steps, taken individually and in sequence, was assessed by 
using a set of 60 chemicals. The alternative methods considered included the use of 
structure-activity relationships (SAR); physicochemical properties (pH measurements 
and acid/alkali reserve), and in vitro tests. Within this strategy, animal tests were only 
used to confirm negative results (non-corrosive) generated by one or more alternative 
methods. In the fist step, two-descriptor prediction models (PM) were derived by 
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binary logistic regression. Separate models were derived for organic acids, organic 
bases, phenols, electrophiles, and neutral organics; they were selected from a range of 
possible PMs on the basis of their statistical significance. The most recurrent 
parameter (appearing in the predictive models of acids, phenols, and electrophiles) 
was LogP, followed by molecular volume (MV) and the melting point (MP), the 
negative logarithm of the dissociation constant (pKa), and dipole moment (DM). In 
the second step, a PM based on the pH was applied to each substance; for pH ≤ 2 or 
pH ≥ 11.5, the substance was classified as corrosive. Although the combined use of 
pH and acid/alkali reserve was evaluated, it turned out not to be relevant. In the final 
step, two in vitro methods were evaluated, i.e. the rat skin transcutaneous electrical 
resistance (TER) assay and the EPISKIN assay. The predictive ability of individual 
steps was 95% for SARs, 77% for pH, and around 82-83% for in vitro tests (Table 1). 
To assess the predictive ability of the sequence of three steps for the tiered testing 
strategy, if a chemical was predicted to be corrosive (C) by one of the alternative 
methods, a C classification was assigned and there was no further progress through 
the strategy. Conversely, if a chemical was predicted to be non-corrosive (NC), it 
entered the next step to check whether the prediction had been a false negative. 
Progress through the strategy continued until the chemical was either predicted to be 
C by one of the alternative methods, or until a classification C/NC was assigned on 
the basis of the results of the rabbit test. The results showed that the sequential 
application of the three alternative methods for the integrated testing strategy allowed 
the classification of chemicals as C or NC with sufficient reliability.  
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Table 1. Prediction models and performance of individual steps in a stepwise testing strategy for 
skin corrosivity [26].  
Step Applicability Predictive Model (PM) 
% Concordance 
(Specificity; 
Sensitivity) 
 for Organic Acids  If 896.6082.0log055.1 ≤+ MPP , C 
 for Organic bases  If 7.15log507.0926.1 ≥− PpKa , C 
 for Phenols  If 634.3log908.1087.0 ≤− PMV , C 
1st step  
 for Electrophiles  If 42.5355.1116.0 ≤− DMMV , C 
95 (86; 100) 
 for Skin Corrosion  If 2≤pH  or if 5.11≥pH , C 77 (56; 94) 
2nd step 
 combined use of pH 
 and acid/alkali reserve  
If pH – acid reserve/6 ≤ 1, or  
If pH + alkali reserve/12 ≥ 14.5, C 
50 (29; 92) 
3rd step 
a different prediction model for each single in vitro endpoint 
(TER, EPISKIN) 
82-83 
(85-93; 73-82) 
 
Prediction Models in the form “If condition, then predict C” 
 (C: Corrosive)  
 
Subsequently, Worth et al. [27] reported a similar study to [26] to evaluate 
stepwise testing strategies for eye irritation/corrosion. The approach was also based 
on the sequential application of three steps involving alternative methods prior to 
animal testing. As in the previous scheme, if any of the alternative methods predicted 
the chemical of interest to be toxic, a classification was assigned and testing was 
stopped. Otherwise, testing continued to the next step. In this way, toxic chemicals 
could be screened out by alternative methods, so that animal tests conducted in the 
final step would mainly serve to confirm predictions of non-toxicity.  
 The three steps were applied both on their own and as a sequence to the 
training set made up of 60 chemicals [26]. The predictivities of nine in vitro tests were 
examined, and PMs were derived to compare their performances. In the first step, two 
PMs based on physicochemical properties were derived, one for aliphatic chemicals 
and the other one for aromatic chemicals. A PM for aliphatic chemicals related dipole 
moment (DM) and LogP; the SAR described a two-dimensional ellipse enclosing 
irritant chemicals and excluding non-irritant chemicals, and it was based on the 
observation that irritant aliphatic chemicals form an embedded cluster within the more 
diffuse cluster of non-irritants. The PM for aromatic chemicals established ranges of 
LogP values to classify I from NI. In the second step, pH ranges to differentiate C 
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from NC, and I from NI (comprised within the previous range) were set. The 
performance of individual steps was 74% concordance for SARs, and 47% for pH. 
Also the combined use of pH acid/alkali reserve was evaluated, resulting in the non-
significant concordance of 45%. In the third step, the single endpoints of in vitro tests 
with lowest false positive rates were evaluated, obtaining comparable results in all the 
cases (between 64 and 79%), as shown in Table 2. 
Table 2. Prediction models and performance of the individual steps of a tiered testing strategy for 
eye irritation [27].  
Step Applicability  Predictive Model (PM) 
% Concordance 
(Specificity; 
Sensitivity) 
for Aliphatics 
(Eye Irritation) If 
( ) ( ) 1
215.0
576.1
002.2
408.1log
2
2
2
2
≤−+− DMP
, I 1st step  
for Aromatics 
(Eye Irritation) 
If 72.2log09.1 ≤≤− P , I 
74 (71; 80) 
for Corrosion If 2≤pH  or if 5.11≥pH , C 
for Eye Irritation If 14.3≤pH  or if 35.9≥pH  , I 
47 (35; 81) 
2nd step  
combined use of pH 
and acid/alkali reserve 
If pH – acid reserve/6 ≤ 1, or  
If pH + alkali reserve/6 ≥ 13, I 
45 (33; 80) 
3rd step a different prediction model for each single in vitro endpoint 
64-79 
(74-100; 0-81) 
 
Prediction Models in the form “If condition, then predict C / I” 
(C: Corrosive / I: Irritant)  
 
Tiered testing strategies for skin corrosion have been developed and assessed 
by Worth and Cronin [28]-[31]. The evaluation of a two-step strategy, based on the 
sequential use of pH measurements and in vitro data, indicated that the combined use 
of these data improved the ability to predict corrosion potential [28]. Subsequently, a 
three-step strategy was reported, based on the sequential use of QSARs, pH 
measurements and in vitro data [26]. A separate study by Worth confirmed the 
usefulness of pH as a predictor of skin corrosion potential, and provided a new 
prediction model (PM) for identifying corrosive chemicals by a pH-dependent 
mechanism [30]. 
Tiered assessment schemes for the prediction of skin irritation and corrosion 
have been designed and evaluated by Worth [32]. The first step of the process 
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consisted of classifying corrosivity based on melting point (MP) and molecular weight 
(MW). This was followed by the use of a classification model (CM) based on pH 
(Step 2). Subsequently, in vitro data from the EPISKIN assay were used (Step 3). If 
the compound was ultimately classified as non-corrosive in the third step, a similar 
iterative process was performed to identify skin irritants. Ultimately, if the compound 
was predicted non-irritant, the in vivo Draize skin test was applied. Thus, the purpose 
of such a scheme was to classify chemicals and to confirm negative classifications 
with the use of animal tests.  
In a subsequent study, Worth et al. [28] evaluated the uncertainty associated 
with the predictive abilities of two-group classification models (CM), expressed in 
terms of Cooper statistics. Standard and percentile bootstrap resampling techniques 
were used to judge whether predicted classifications were significantly better than the 
predictions made by a different CM, or whether the performance of a CM exceeded 
predefined performance criteria in a statistically significant way. This method was 
illustrated by constructing 95% confidence intervals (CI) for the Cooper statistics of 
four alternative skin corrosivity tests (TER, EPISKIN, Skin2, and CORROSITEX), as 
well as two-step sequences in which each in vitro test was used in combination with a 
physicochemical test for skin corrosion based on pH measurements. The PMs were 
applied to a dataset of 60 chemicals already published [26]. Cooper statistics were 
used to determine whether the four two-step sequences, with sensitivities greater than 
or equal to 70%, were significantly more predictive than the four stand-alone in vitro 
tests. This study showed that the performances of the TER, EPISKIN, Skin2 and 
CORROSITEX tests in combination with the pH test were better than the individual 
performances of the in vitro tests (Table 3). 
Table 3. Classification results of the individual in vitro tests and the in vitro tests in sequence with 
the pH test. 
 Bootstrap mean estimates 
In vitro test Concordance Sensitivity Specificity 
TER 78 83* 87 96* 71 73* 
EPISKIN 81 88* 83 96* 80 82* 
Skin2 75 83* 45 70* 100 94* 
CORROSITEX 73 74* 71 72* 76 78* 
  * Use of the in vitro test in sequence with the pH test 
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The bootstrap resampling technique was subsequently applied to assess the 
variability of Draize tissue scores to estimate acute dermal and ocular effects [29]. 
This technique was used to estimate biological variability arising from the use of 
different animals, and temporal variability arising from different time-points. The 
estimates of variability where then used to determine the extent to which Draize skin 
and eye test tissue scores could be predicted. A dataset of 143 ECETOC chemicals 
was used for the variability of Draize skin scores, while for eye scores the dataset 
consisted of 92 ECETOC chemicals. The results indicated that the variability in 
Draize skin scores was such that no model for predicting PII could be expected to 
have r2>0.57; in contrast, the variability in Draize eye scores was such that no model 
for predicting MMAS could be expected to have r2> 0.81.  
 Gerner and Schlede [33] reviewed the introduction of in vitro data into local 
irritation/corrosion testing strategies; these tiered testing strategies combine in vitro 
tests and SARs. They reported several strategies, from the more general assessment of 
acute toxic hazard (Figure 5), to the classification of the skin corrosion potential 
(Figure 6), and the local irritation potential (Figure 7).  
 The assessment and classification of the acute toxicity of a chemical observed 
after swallowing of the substance, after inhalation of its gases, vapours or aerosols 
and/or after skin contact was deduced from the results of standardised testing with 
rodents. It was assumed that if corrosive effects in contact with skin were observed, 
corrosivity in the stomach or in lungs by oral ingestion or inhalation could be 
predicted. This observation enabled a differentiation between dangerous substances 
because of their universal corrosive properties and substances exhibiting corrosion 
exclusively in contact with skin. Those chemicals should be tested for oral and 
inhalation toxicity irrespective of their corrosive properties, because they could cause 
systemic effects after oral or inhalation exposure not related to their corrosive dermal 
properties. The aim of this strategy was to avoid or reduce acute dermal toxicity 
testing of skin corrosive chemicals. 
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Figure 5. Tiered testing and assessment strategy for acute toxicity of chemicals [33].  
 
 Since skin corrosivity is considered as a crucial effect, the assessment of the 
skin corrosion potential of a chemical should be performed prior to any animal testing 
according to international test guidelines. Thus, development and validation of in vitro 
tests for the replacement of the Draize skin test by non-animal alternatives have been 
intensively explored. These efforts resulted in the European Test Guideline B.40 Skin 
Corrosion [34] which was adopted by the EU Member States in 2000. The OECD 
developed a testing and assessment strategy in order to provide guidance on how to 
base hazard classification on data obtained with in vitro or ex vivo methods. 
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Figure 6. Assessment of skin corrosion potential of chemicals (classification according to EU 
regulations) [33].  
 
 
 
The testing and assessment strategy for the classification of skin and eye 
irritation/corrosion within the GHS was also reported [35]. It was demonstrated that, 
for a proper assessment and classification of local irritation caused by a single contact 
with skin or eyes, three different kinds of in vitro or ex vivo data could replace 
irritation testing with rabbits: testing for moderate skin irritation; testing for serious 
eye damage; and testing for moderate eye irritation. 
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Figure 7. Tiered testing and assessment strategy for local irritation potential of chemicals 
(classification according to EU regulations) [33].  
 
A subsequent paper by the same author [36] published structural alerts for the 
classification and labelling of eye irritation/corrosion hazards according to 
international classification criteria. Physicochemical limit values for prediction of the 
absence of any eye irritation potential relevant for human health were also published. 
These detailed testing and assessment strategies are included in the annex to the 
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current OECD TG 405 for eye irritation/corrosion testing and the GHS [35], as shown 
in Figure 8.  
Figure 8. Testing and evaluation strategy for eye irritation/corrosion proposed by the OECD 
[36]. 
 
Testing and assessment strategies composed of structural alerts and in vitro 
tests to be used within the applicability domains defined by physicochemical limit 
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values and used to classify and label chemicals on the basis of their hazardous 
properties, as well as to assist in the selection of experimental test methods for the 
assessment of chemicals are shown in Figure 9. 
Figure 9. Testing and assessment strategies for the prediction of eye irritation/corrosion by using 
physicochemical limit values, structural alerts and the results of specific in vitro tests, as 
implemented within computerised expert systems for the classification of eye hazards [36]. 
 
 A recent paper of Walker et al. [37] reports the so-called Skin Irritation 
Corrosion Rules Estimation Tool (SICRET) that was developed to estimate whether 
chemicals are likely to cause skin irritation or skin corrosion. SICRET is a tiered 
approach that uses physicochemical property limits, structural alerts and in vitro tests 
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to identify and classify chemicals that cause skin irritation or skin corrosion without 
animal testing. SICRET uses physicochemical property limits to identify chemicals 
with no skin corrosion or skin irritation potential; if the exclusion physicochemical 
rules do not identify the chemicals with no skin corrosion or skin irritation potential, 
then the structural alerts are used to identify chemicals with skin corrosion or skin 
irritation potential. If a chemical does not contain structural alerts that indicate it has 
skin corrosion or skin irritation potential, then in vitro skin corrosion or skin irritation 
testing is evaluated. If the in vitro test is positive, then the data are included in 
feedback loops for development of new structural alerts to identify chemicals with 
skin corrosion or skin irritation potential. If the in vitro test is negative then the data 
are included in feedback loops for development of new physicochemical property 
limits to identify chemicals with no skin corrosion or skin irritation potential.  
SICRET is a tiered approach that it has been proposed to complement the 
current OECD skin corrosion and skin irritation testing strategy as described in TG 
404 for acute dermal irritation/corrosion. A significant difference between SICRET 
and the strategy described in the OECD TG 404 is that the former only uses 
information from in vitro tests, whereas the latter also uses in vivo tests information. 
Although the in vitro corrosion testing proposed by SICRET has been adopted by the 
OECD member states, in vitro skin irritation tests have not been yet validated. After 
the external validation of the physicochemical property limits and the structural alerts, 
SICRET software is planned to be coded to allow users determining whether a 
chemical is likely to cause either skin irritation or skin corrosion by providing a 
probability.  
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5. Proposed Integrated Testing Strategy for REACH 
In the current regulation panorama, one of the objectives within the REACH 
Implementation Project (RIP) 3.3 was to create and test an Integrated Testing Strategy 
(ITS) for irritation and corrosion [38]-[40]. This strategy takes into account all data 
sources, including: non-testing information, in vivo and in vitro testing information, 
field and human data. The aim of the developed ITS is also to enable hazard 
assessment and classification of a chemical substance via a stepwise procedure that is 
cost efficient and scientifically sound whilst taking into account animal welfare 
concerns by reference to all existing data before considering in vivo testing. Earlier 
references dealing with the use of testing and waiving strategies in the context of 
REACH can be found at [41]-[43].  
More recently, a series of papers on detailed suggestions for applying non-
animal methods to each of the major toxicity endpoints in REACH have been 
published [3]-[4], [44]-[45]. Some of them review the status of alternative approaches 
to animal testing, and systems for the safety testing and risk assessment of chemicals 
[44]. Others present individual, decision-tree strategies for the eleven major toxicity 
endpoints of the REACH system, including human health effects and ecotoxicity [45]. 
According to the REACH proposal, there are data and testing requirements for 
skin and eye irritation/corrosion for all substances produced in the EU or imported at 
levels greater that a tonne per year. Before testing, all relevant physicochemical and 
toxicological information e.g. acid or alkaline reactions, human and animal data, in 
vitro test data and (Q)SAR analysis, should be assessed. If these data are not available 
or they are inadequate for hazard and risk assessment, an in vitro skin corrosion study 
is normally required. Where the substance is corrosive in the in vitro study, it should 
be classified accordingly and no further testing for irritation conducted. However, if 
the substance is not corrosive in this study an in vitro test for skin irritation and 
normally an in vitro eye irritation study should be undertaken. If there are positive in 
vitro results from these studies the substance should be classified as being irritating to 
skin and eyes. When a level of 10 tonnes per year is exceeded, in vivo skin and eye 
irritation tests are normally required, unless the substance is already classified in 
which case the corresponding in vivo testing need not be done. In the scoping study of 
RIP 3.3, two similar sequential test strategies for skin and eye irritation/corrosion 
 28 
were proposed for substances with no or very few data [39]. These ITS, similar to the 
sequential testing strategy proposed by B.4 [18] and B.5 [19] for skin and eye 
irritation/corrosion, respectively, are recommended for assessment and classification 
of the corrosive and irritating properties of substances. For existing substances with 
insufficient data, this strategy can be used to decide which additional data are needed. 
 A risk assessment of the irritating potential of a substance is normally made in 
a qualitative way when the substance has been classified as being irritating/corrosive 
to skin. If the substance is not classified for skin irritation/corrosion, no risk 
assessment for this endpoint is performed, regardless of the exposure. Therefore, 
classification is a key determinant in this strategy.  
 Both ITS for skin and eye irritation/corrosion include three parts (Figure 10) 
retrieval of existing information, 2) Weight of Evidence (WoE) analysis and 
judgement of existing data and 3) generation of new information by testing if 
necessary. In the information retrieval part, existing and available information from 
the literature and databases is gathered and considered in a stepwise process. At the 
end of this part all information collected is analysed using a WoE approach (step 7), 
which establishes whether in vitro or in vivo tests should be conducted. It is 
recommended that the strategy is followed to step 6 in all cases and thereafter the 
WoE analysis is performed. Before the WoE analysis in step 7, no new in vitro or in 
vivo tests should be conducted, but the assessment should be based on the existing 
data. In the information generation part, new information on the irritation potential of 
substances is created by means of testing. Prior to perform any new in vivo test, the 
use of in vitro methods should be fully exploited. Both the second and third parts may 
either lead to a decision on classification and labelling or an informed decision that 
there is no necessity to classify/label.  
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Figure 10. Overview of the ITS for dermal and ocular corrosion/irritation [40].  
 
Detailed information and guidance on the various steps, addressing skin and 
eye effects separately, is provided in the RIP 3.3 scoping study report [39], and in the 
RIP3.3 phase 2 report [40]. ITS for assessing the skin irritation/corrosion and eye 
irritation potential of substances are displayed in Figure 11 and Figure 12, 
respectively. 
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Figure 11. Integrated testing strategy (ITS) for assessing the skin corrosion and skin irritation 
potential of substances [40].  
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Figure 12. Integrated testing strategy (ITS) for assessing the eye irritation potential of substances 
[40].  
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6. Conclusions 
The further development and validation of testing strategies and in silico approaches 
is necessary. In particular, a considerable effort to evaluate and promote the use of 
valid (Q)SARs is being carried out by the European Chemicals Bureau (ECB) [46]-
[47]. This includes the need to present information on the characteristics of the 
models in a transparent way. At present, QSAR Model Reporting Formats (QMRFs) 
have been developed for several models that predict skin/eye irritation/corrosion, for 
this purpose [48]. 
 The most effective approach to build testing systems is to integrate all 
appropriate information to make a Weight of Evidence (WoE)-based assessment of 
the chemical hazard and risk [8]. Integrated Testing Strategies (ITS) combine all 
possible sources of information from (Q)SARs, expert systems, read-across and other 
grouping approaches, and test methods (especially in vitro tests). Considerable work 
have been carried out within the context of the REACH-Implementation Projects (RIP 
3.3) [40] to develop further existing tiered approaches for the assessment of skin and 
eye irritation/corrosion potential. At the same time, the conceptual framework for 
integrating different components of ITS and weighing their data needs to be further 
investigated. 
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Abstract 
 
This report reviews the use of stepwise testing approaches for the prediction of skin and eye irritation and 
corrosion in a regulatory context. It is published as a companion report to the Review of Literature-Based 
Models for Skin and Eye Irritation and Corrosion, an ECB report which reviewed the state-of-the-art of in 
silico and in vitro dermal and ocular irritation and corrosion human health hazard endpoints. In the former 
review, the focus was placed on reviewing alternative in silico approaches to assess acute local toxic 
effects, such as QSARs, SARs, chemical categories, and read-across and analogue approaches. Special 
emphasis was placed on literature-based (Q)SAR models for skin and eye irritation and corrosion and 
expert systems. In the present review, the emphasis is on different schemes (testing strategies) that have 
been conceived for the integrated use of different approaches, including in silico, in vitro and in vivo 
methods. 
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